Literature DB >> 17081185

Consensus on the management of obstetric cholestasis: National UK survey.

M M Saleh1, K R Abdo.   

Abstract

An anonymous questionnaire was sent to the lead consultant obstetricians and the midwives in charge of the antenatal clinics of all maternity units in UK to determine their current views on the diagnosis and management of obstetric cholestasis (OC). The response rate was 60%. Management policies were broadly similar and consistent with those recommended in the current literature. However, the survey highlighted areas for improvement. Based on the findings of this survey, a consensus view of the management of OC in UK is achievable.

Entities:  

Mesh：

Year:  2006        PMID： 17081185     DOI： 10.1111/j.1471-0528.2006.01102.x

Source DB:  PubMed          Journal:  BJOG        ISSN： 1470-0328            Impact factor:   6.531


  9 in total

1.  Glutamine synthetase in newborn mice homozygous for lethal albino alleles.

Authors:  S Gluecksohn-Waelsch; M B Schiffman
Journal:  Dev Biol       Date:  1975-08       Impact factor: 3.582

2.  Operative delivery rates following induction of labour for obstetric cholestasis.

Authors:  Jessica R Webster; Lucy Chappell; Floria Cheng; Andrew C G Breeze; Nuala Lucas; Felicity Plaat; Catherine Williamson
Journal:  Obstet Med       Date:  2011-05-24

3.  Intrahepatic cholestasis of pregnancy: an evaluation of obstetric management in German maternity units.

Authors:  Leonie Zehner; Maria Mai; Anna M Dückelmann; Amr Hamza; Christel Eckmann-Scholz; Nicolai Maass; Ulrich Pecks
Journal:  Arch Gynecol Obstet       Date:  2022-08-28       Impact factor: 2.493

4.  Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial.

Authors:  Lucy C Chappell; Vinita Gurung; Paul T Seed; Jenny Chambers; Catherine Williamson; James G Thornton
Journal:  BMJ       Date:  2012-06-13

5.  Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.

Authors:  Jielian Yang; Chong Chen; Min Liu; Shuye Zhang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

6.  Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.

Authors:  L B Manna; C Ovadia; A Lövgren-Sandblom; J Chambers; S Begum; P Seed; I Walker; L C Chappell; H-U Marschall; C Williamson
Journal:  BJOG       Date:  2019-09-26       Impact factor: 6.531

7.  Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis.

Authors:  Vinita Gurung; Catherine Williamson; Lucy Chappell; Jenny Chambers; Annette Briley; Fiona Broughton Pipkin; Jim Thornton
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-16       Impact factor: 3.007

8.  Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).

Authors:  Lucy C Chappell; Jenny Chambers; Peter H Dixon; Jon Dorling; Rachael Hunter; Jennifer L Bell; Ursula Bowler; Pollyanna Hardy; Edmund Juszczak; Louise Linsell; Catherine Rounding; Anne Smith; Catherine Williamson; Jim G Thornton
Journal:  Trials       Date:  2018-11-27       Impact factor: 2.279

9.  Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.

Authors:  Lucy C Chappell; Jennifer L Bell; Anne Smith; Louise Linsell; Edmund Juszczak; Peter H Dixon; Jenny Chambers; Rachael Hunter; Jon Dorling; Catherine Williamson; Jim G Thornton
Journal:  Lancet       Date:  2019-08-01       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.